The magazine's distinguished the top 10 states by the number of high-tech businesses in the state, programs that support entrepreneurs, and STEM (science, technology, engineering and mathematics) job concentration. To learn about Maryland startups that are centered around a Johns Hopkins technology, visit the Enterprise Development section of our website, www.techtransfer.jhu.edu.

Heading to NIH's 6th Annual Career Symposium? Hear from JHTT Licensing Associate Aditi Martin during the Careers in Law, Technology Transfer and Consulting panel. The 6th Annual NIH Career Symposium highlights the diversity of career choices available to biomedical researchers. New graduate students, post-docs, or clinical fellows just beginning to consider career options are invited to attend the NIH Career Symposium. Learn more at http://tinyurl.com/NIH6-Career

Join Johns Hopkins Technology Transfer at the 2013 BIO International Convention in Chicago, IL. Visit us at Booth 1423 in the BIOMaryland Pavilion to learn about our latest technology offerings. Can't Make it to BIO? Review Johns Hopkins' technology offerings now at www.jhttonline.jhu.edu or check out our latest fast fact booklet at http://issuu.com/jhtt/docs/bio2013_final_web.

Join Johns Hopkins Technology Transfer at the 2013 American Association for Cancer Research Annual Meeting. Visit us at Booth 340 to learn about our latest oncology portfolio and to speak to a licensing associate. Want to hear from our inventors? Attend their poster sessions and presentations at the conference: http://www.techtransfer.jhu.edu/documents/AACR2013_InventorPresentations.PDF. Can't make it to AACR? Review Johns Hopkins' oncology portfolio now: http://issuu.com/jhtt/docs/aacr2013_web040123/1.

Johns Hopkins researchers have developed an implant for the application of drugs directly to the sinuses. The device consists of a catheter that allows drugs to reach previously inaccessible surfaces. It is easily implanted in the nasal cavity after surgery or during an office visit. The device also features a novel magnetic fixture to connect the drug injectors. This feature creates a reliable seal for efficient medication passage. The unique construction prevents inflammation from blocking delivery to areas that need treatment the most.

Johns Hopkins researchers have developed “PapGene” test, a new screening method for endometrial and ovarian cancers. This diagnostic test is easily incorporated into a routine pelvic examination. The invention uses a sequence-based method to query 12 mutations in a single liquid Pap smear. Additionally, this method does not require prior knowledge of the tumor’s genotype. This diagnostic test provides and inexpensive and accurate means of diagnosing ovarian and endometrial cancers.